Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Caporali

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
Nephron|January 1, 1996
Lack of evidence of antineutrophil cytoplasmic antibodies involvement in the acute phase of thrombotic thrombocytopenic purpura. Italian Cooperative Group for TTPC Porta, R Caporali, C Montecucco, et al.
Scandinavian Journal of Rheumatology|July 29, 2020
Is there really room for anti-rheumatic drugs in the treatment of COVID-19?E G Favalli, F Ingegnoli, M Biggioggero, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1987
[Sicca syndrome associated with systemic lymphoproliferative disease. Clinico-pathologic and serologic profile of 11 cases]M Longhi, R Caporali, R Carnevale, et al.
Acta Neurologica|June 1, 1994
Multiple sclerosis and Sjögren's syndromeD Franciotta, C M Montecucco, R Caporali, et al.
Haematologica|March 1, 1989
Hematological abnormalities associated with anticardiolipin antibodiesC Montecucco, M Longhi, R Caporali, et al.
Archives of Disease in Childhood|November 1, 1992
Antiphospholipid antibody associated thrombosis in juvenile chronic arthritisR Caporali, A Ravelli, B Ramenghi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 1, 2022
Reply to: appropriate dosing of burosumab in tumor-induced osteomalaciaC Crotti, F Zucchi, C Alfieri, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 4, 2022
Long-term use of burosumab for the treatment of tumor-induced osteomalaciaC Crotti, F Zucchi, C Alfieri, et al.
The Journal of Rheumatology|December 1, 1992
Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoidsC Montecucco, R Caporali, P Caprotti, et al.
Reumatismo|July 26, 2013
Diffuse alveolar hemorrhage as a manifestation of Behçet diseaseV Grosso, E Boveri, L Bogliolo, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Nephron|January 1, 1996
Lack of evidence of antineutrophil cytoplasmic antibodies involvement in the acute phase of thrombotic thrombocytopenic purpura. Italian Cooperative Group for TTPC Porta, R Caporali, C Montecucco, et al.
Scandinavian Journal of Rheumatology|July 29, 2020
Is there really room for anti-rheumatic drugs in the treatment of COVID-19?E G Favalli, F Ingegnoli, M Biggioggero, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1987
[Sicca syndrome associated with systemic lymphoproliferative disease. Clinico-pathologic and serologic profile of 11 cases]M Longhi, R Caporali, R Carnevale, et al.
Acta Neurologica|June 1, 1994
Multiple sclerosis and Sjögren's syndromeD Franciotta, C M Montecucco, R Caporali, et al.
Haematologica|March 1, 1989
Hematological abnormalities associated with anticardiolipin antibodiesC Montecucco, M Longhi, R Caporali, et al.
Archives of Disease in Childhood|November 1, 1992
Antiphospholipid antibody associated thrombosis in juvenile chronic arthritisR Caporali, A Ravelli, B Ramenghi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 1, 2022
Reply to: appropriate dosing of burosumab in tumor-induced osteomalaciaC Crotti, F Zucchi, C Alfieri, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 4, 2022
Long-term use of burosumab for the treatment of tumor-induced osteomalaciaC Crotti, F Zucchi, C Alfieri, et al.
The Journal of Rheumatology|December 1, 1992
Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoidsC Montecucco, R Caporali, P Caprotti, et al.
Reumatismo|July 26, 2013
Diffuse alveolar hemorrhage as a manifestation of Behçet diseaseV Grosso, E Boveri, L Bogliolo, et al.
Pageof 13